Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides
More topics under "C07K - Peptides" (616,656)
C07K 1 - General processes for the preparation of peptides (51,718)
C07K 11 - Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof (895)
C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
C07K 19 - Hybrid peptides (29,428)
C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
Patents for C07K - Peptides (3,738)
03/1993
03/30/1993CA1315229C Chromatographic purification process
03/23/1993CA1315042C2 Methods and compositions for preparation of the tetrapeptide, h-x-omega-u-z-y-tyr-r'
03/23/1993CA1315041C2 Methods and compositions for preparation of the tetrapeptide, alpha-t-x-omega-u-z-y-tyr-r'
03/23/1993CA1315040C2 Methods and compositions for preparation of the pentapeptide, alpha-t-omega-t' -arg-x-omega-u-z-y-tyr-r'
02/1993
02/04/1993WO1993002108A1 Recombinant antibodies for human therapy
01/1993
01/13/1993EP0522152A1 Lhrh antagonists
01/13/1993EP0216833B1 Novel insulin derivatives and pharmaceutical preparations containing these derivatives
01/07/1993WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof
01/07/1993CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof
12/1992
12/23/1992WO1992022583A2 Tri- and tetra-valent monospecific antigen-binding proteins
12/23/1992EP0519547A2 Coccidiosis poultry vaccine
12/19/1992CA2071395A1 Coccidiosis poultry vaccine
12/15/1992US5171835 LHRH antagonists
12/10/1992WO1992014818A3 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
11/1992
11/26/1992WO1992020798A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2¿
11/26/1992WO1992020709A1 Galanin antagonist
11/26/1992CA2109503A1 Galanin antagonist
11/25/1992EP0515228A2 Essential pure human parathyroid hormone
11/25/1992CA2331239A1 Structure, production and use of heregulin
11/19/1992EP0514361A1 Galanin antagonist
11/03/1992CA1309671C Monoclonal antibodies to cyclosporins
10/1992
10/28/1992EP0510356A1 Polyethylene glycol protein conjugates
10/28/1992EP0504291A4 Novel proteins with oncostatin m activity and process for their preparation
10/21/1992CN1065465A Polyethylene protein conjugates
10/14/1992CN1065293A Entomopoxvirus expression system
10/06/1992WO1992017503A1 Method for the production of collagen; collagen produced through the method and use of collagen
10/06/1992US5153312 Respiratory system disorders
10/06/1992CA2107680A1 Method for the production of collagen; collagen produced through the method and use of collagen
09/1992
09/29/1992WO1992017568A1 A cDNA CLONE ENCODING A HUMAN NOREPINEPRHINE TRANSPORTER
09/29/1992CA2106190A1 Cdna clone encoding a human norepinephrine transporter
09/23/1992EP0504363A1 PURIFIED IgG ANTIBODIES
09/23/1992EP0504291A1 Novel proteins with oncostatin m activity and process for their preparation
09/09/1992CN1064217A Pneumococcal polysaccharide conjugate vaccine
09/02/1992EP0500734A1 Protein complexes having factor viii:c activity and production thereof
08/1992
08/25/1992US5141905 Bone morphogenic proteins induce bone and/or cartilage formation
08/20/1992WO1992014818A2 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
08/20/1992WO1992013883A1 Lhrh antagonists
08/20/1992CA2103550A1 Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences
08/20/1992CA2079461A1 Lhrh antagonists
08/19/1992EP0340245B1 Substituted alkylamides of teicoplanin compounds
08/12/1992EP0456766A4 Type oc platelet-derived growth factor receptor gene
08/05/1992EP0497525A2 Pneumococcal polysaccharide conjugate vaccine
08/04/1992CA1305931C Yeast strains producing cellulolytic enzymes and methods and means for constructing them
07/1992
07/22/1992EP0327548B1 Glycopeptide antibiotics
07/21/1992US5132287 Methods of treating disorders which cause conglutinin deficiency
07/15/1992CN1017451B Method for the preparation of vaccine
07/15/1992CN1017436B Peptide containing immunoexcitant
06/1992
06/30/1992US5126273 Monitoring method for the synthesis of a linear conbination of amino acid residues
06/17/1992EP0357637B1 General cancer-associated scm-recognition factor, preparation and method of use
06/09/1992CA1302883C Method of preparing toxoid
05/1992
05/29/1992CA2056143A1 The mac-1 binding site of icam-1
05/13/1992EP0484380A1 Uses of interleukin-4 and method for purifying it
05/06/1992CN1060871A Novel onco-fetal gene, gene product and uses therefor
04/1992
04/30/1992WO1992007084A1 Purified cdw52-specific antibodies
04/29/1992EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus
04/28/1992US5109119 Concentrated and equilibrated in polyoxyethylene glycol solution
04/15/1992CN1060294A Improved oligosaccharide conjugate vaccines
04/02/1992WO1992006218A1 A novel onco-fetal gene, gene product and uses therefor
04/02/1992CA2092916A1 Onco-fetal gene, gene product and uses therefor
04/01/1992EP0477508A1 Improved oligosaccharide conjugate vaccines
03/1992
03/25/1992EP0476022A1 Crystalline r-h-gm-csf and method for the preparation
03/18/1992EP0216786B1 Purification, production and use of tumor necrosis factors
03/11/1992CN1059278A 抗体共轭物 Antibody conjugate
02/1992
02/11/1992CA1295784C Peptide immunostimulants
01/1992
01/20/1992CA2050635A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties, and vaccines containing same
01/20/1992CA2047043A1 Class ii protein of the outer membrane of neisseria meningitidis having immune enhancement properties
01/20/1992CA2047030A1 Class ii protein of the outer membrane of neisseria meningitidis having immunologic carrier and enhancement properties
01/15/1992CN1057785A Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof
01/15/1992CN1057784A Growth hormone releasing factor analogs
01/02/1992EP0463072A1 Novel insulin compounds.
12/1991
12/27/1991EP0462192A1 Glycosylated insulins
12/11/1991EP0460189A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
11/1991
11/26/1991US5068314 Lipopolysaccharide-binding polypeptide
11/21/1991EP0456766A1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE
11/14/1991WO1991017248A1 Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
11/14/1991DE4014510A1 Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie Variant CD44-oberflaechenproteine, this encoding c-dna sequences, antibodies against these proteins and their use in the diagnosis and therapy
10/1991
10/31/1991WO1991016061A1 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF
10/31/1991CA2059289A1 Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof
10/30/1991EP0454367A2 Growth hormone releasing factor analogs
10/25/1991CA2040649A1 Growth hormone releasing factor analogs
10/16/1991CN1055389A Novel proteins with oncostatin m activity and process for their preparation
09/1991
09/11/1991EP0445796A2 Derivatives of acetic acid
09/10/1991CA2037153A1 Acetic acid derivatives
09/06/1991CA2037238A1 Method for treating pneumocystis pneumonia
09/05/1991WO1991013092A1 Vasoactive vasotocin derivatives
08/1991
08/13/1991WO1991012020A1 Novel vaccine and method therefor
08/07/1991EP0257053B1 Monitoring method for the synthesis of a linear combination of amino acid residues
07/1991
07/02/1991US5028586 Eliminating some or all of the acid containing side chains by esterification or replacement of glutamic acid residues with glutamine, prolonged action
06/1991
06/27/1991WO1991009057A1 Novel proteins with oncostatin m activity and process for their preparation
06/27/1991WO1991008762A1 Production of biologically active platelet-derived growth factor from high expression host cell systems
06/27/1991CA2070171A1 Proteins with oncostatin m activity and process for their preparation
06/18/1991CA1285099C2 Methods and compositions for preparation of h-arg-x-z-y-tyr-r
06/13/1991WO1991008225A1 Hexapeptides with sulphate ester groups
06/05/1991CN1051937A Stem cell factor
06/05/1991CN1051936A Drythropoietin isoforms
05/1991
05/28/1991CA2030720A1 Hexapeptides with sulphate ester groups
05/22/1991EP0428267A2 Erythropoietin isoforms
05/21/1991US5017687 Polypeptides Immunologically Reactive With HTLV Antibodies
05/18/1991WO1991007490A1 Protein complexes having factor viii:c activity and production thereof
05/18/1991CA2135744A1 Protein complexes having factor viii:c activity and production thereof
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38